Explore answers to our most commonly asked questions about CBD, our products, and more.
ARA-290, also known as cibinetide in the literature, is a short peptide derived from the tissue-protective region of erythropoietin. It is studied because it appears to engage protective signaling without behaving like erythropoietin in the classic red-blood-cell sense. For site copy, it should be presented as a research peptide only.
Researchers usually investigate ARA-290 in models involving inflammation, tissue protection, and neuropathic or matrix-related signaling. A key point is that it is generally discussed as a non-erythropoietic EPO-derived peptide, meaning the research interest is protective signaling rather than stimulation of red blood cell production.
Subscribe to receive your promo code and occasional email updates about new research materials.
By subscribing, you agree to our Privacy and Cookie Policy and Terms & Conditions.
Our agents are here to help you.
The products on this website are for legitimate research use only. They are not intended to prevent, treat, or cure any illness or disease and are not intended for human consumption. By accessing this site, you acknowledge that you are at least 21 years of age, understand these terms, and have a legitimate research basis for buying these products.
NOTE: All of our compounds are sold individually and are supplied as research materials only. Laboratory consumables are not included, and we do not provide reconstitution, administration, or human-use instructions.
